PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Finding about classic suppressor of immunity points toward new therapies for bad infections

2014-01-08
(Press-News.org) Contact information: Toni Baker
tbaker@gru.edu
706-721-4421
Medical College of Georgia at Georgia Regents University
Finding about classic suppressor of immunity points toward new therapies for bad infections

AUGUSTA, Ga. - A well-documented suppressor of immunity that's used by fetuses and tumors alike, just may be able to change its spots, researchers report.

In the face of a significant bacterial infection, for example, indoleomine 2,3-dioxegenase, or IDO, also appears capable of helping key immune cells called macrophages produce inflammation to destroy the invader, said Dr. Tracy L. McGaha, immunologist at the Medical College of Georgia at Georgia Regents University and GRU Cancer Center.

The surprising finding points toward new therapeutic targets when inflammation goes overboard, known as a cytokine storm, as with the overwhelming and highly lethal infection septicemia.

"It's always described as a one-way street, but it appears IDO has a dual role," said McGaha, corresponding author of the study in the journal Molecular and Cellular Biology. "It promotes inflammation when it needs to and, where there is no need for classic inflammation, it can immediately switch to a suppressant mechanism," McGaha said.

IDO's upregulation in macrophages helps these immune cells make important decisions about whether to ignore or attack. "It just depends on the environment the cell finds itself in," McGaha said. He and others also are showing that macrophages, well-documented garbage consumers in the body, have this larger role as well as a driver of the immune response.

While studying more about IDO's role in modulating macrophages response to cell debris, McGaha and his colleagues found that when they added a piece of a bacterial cell wall to prompt an inflammatory reaction, they found an increased number of IDO-expressing macrophages in the mix, which seemed counterintutitive considering IDO's role as a suppressor, McGaha said.

That's how they learned IDO actually does both. IDO basically works by degrading the essential amino acid tryptophan, producing a stress response in the now-starving cell that prompts an increase in the stress response kinase GCN2, which essentially shuts down protein production and cell activity. Unless there is another stressor, which is what happened when the researchers added the bacterial cell wall.

In this infection model, high levels of GCN2 appear instead to nudge macrophages to make more pro-inflammatory mediators, resulting in rampant inflammation in the mice. In this environment, gene activity goes up to the point that the previously sluggish protein production is revived. "The overall affect is you get more inflammation," McGaha said.

And that's where potential new therapies for selectively blocking inflammation surfaced. When they knocked out GCN2, severe inflammation decreased and survival increased in animal models of septicemia. McGaha hopes the laboratory findings will eventually translate to hospital intensive care units.

"Macrophages can do a lot of things and only one of them is make inflammatory products, like cytokines, in response to infection," McGaha said. "They also are involved in wound healing and tissue reconstitution maitenance. So if a macrophage comes into an area that has a lot of mechanical damage, say from trauma, you don't want to make proinflammatory things because that will hurt the ability of the tissue to heal itself."

The good news is that drugs that block GCN2 already are under development to fight cancer and agonists exist that could bolster a positive immune response, such as increasing the potency of a vaccine, McGaha said. "If we can manipulate GCN2's activity in various contexts, we can help finetune the immune response in the direction we want."

Next steps including looking at how GCN2 manipulates immunity, particularly its impact on protein production.

MCG's Drs. Andrew Mellor and David Munn were the first to report that the fetus expresses IDO to help avoid rejection by the mother's immune system. Subsequent studies have shown tumors also use IDO for protection and clinical trials are studying the tumor-fighting potential of an IDO inhibitor. On the flip side, there is evidence that increasing IDO expression can protect transplanted organs and counter autoimmune disease. Mellor and Munn are co-authors on the new study, which was supported in part by the National Institutes of Health and Wellcome Trust.



INFORMATION:



ELSE PRESS RELEASES FROM THIS DATE:

Study: 'Living Room' offers alternative treatment for emotional distress

2014-01-08
Study: 'Living Room' offers alternative treatment for emotional distress Patients perceive nonclinical care setting as 'helpful and positive' CHICAGO — Emergency departments may not be the best choice for persons suffering from severe mental illness or emotional distress. ...

AGU journal highlights -- Jan. 7, 2014

2014-01-08
AGU journal highlights -- Jan. 7, 2014 The following highlights summarize research papers that have been recently published in Geophysical Research Letters (GRL) and Water Resources Research (WRR). In this release: Kīlauea magma chamber inflation triggered ...

Microbe community changes may reduce Amazon's ability to lock up carbon dioxide

2014-01-08
Microbe community changes may reduce Amazon's ability to lock up carbon dioxide UT Arlington researchers focusing on the Amazon recently found that widespread conversion from rainforest to pastureland has significant effects on microorganism communities that ...

New research study: The snowball effect of overfishing

2014-01-08
New research study: The snowball effect of overfishing TALLAHASSEE – Florida State University researchers have spearheaded a major review of fisheries research that examines the domino effect that occurs when too many fish are harvested from one habitat. The ...

The epigenetics of breast cancer family history

2014-01-08
The epigenetics of breast cancer family history Breast cancer runs in families; however, genetic predisposition (such as being BRCA1 or BRCA2 mutation carriers) explains only a portion of this observation. Epigenetic changes (modifications in the genome that alter gene ...

Perceived benefits of e-cigarettes may lead to higher experimentation rates

2014-01-08
Perceived benefits of e-cigarettes may lead to higher experimentation rates New study finds link between common beliefs and e-cigarette use among young adults Ann Arbor, MI, January 7, 2014 – Despite years of anti-smoking education and legislation, tobacco use still ...

Health and wealth connected?

2014-01-08
Health and wealth connected? By studying Google search data, researchers led by SDSU professor John Ayers discovered Americans had more health concerns during the recession SAN DIEGO, Calif. (Jan. 7, 2014)—We ring in the New Year with hopes of being healthy, wealthy, ...

Special focus issue on sepsis

2014-01-08
Special focus issue on sepsis A special issue on sepsis has been released by the publisher Landes Bioscience (Austin, TX USA). The articles contained in this special issue of the journal Virulence have been authored by world-class investigators and provide new insights ...

New research may boost drug efficacy in treating pulmonary arterial hypertension

2014-01-08
New research may boost drug efficacy in treating pulmonary arterial hypertension Intravenous/sublingual tissue-penetrating homing peptide enhances activity of other pulmonary drugs, according to new research published in the American Journal of Pathology Philadelphia, ...

8 million lives saved since surgeon general's tobacco warning 50 years ago

2014-01-08
8 million lives saved since surgeon general's tobacco warning 50 years ago Yale study on the impact of anti-smoking measures that began half a century ago A Yale study estimates that 8 million lives have been saved in the United States as a result of anti-smoking measures ...

LAST 30 PRESS RELEASES:

Novel treatment combination improves progression-free survival in metastatic, estrogen-receptor-positive HER-2-negative breast cancer

ESMO 2025: Trial results show belzutifan shrinks rare neuroendocrine tumors and improves symptoms in patients

ESMO 2025: Dual targeted therapy shows promise in previously treated advanced kidney cancer patients

New generation of Antibody-Drug Conjugates (ADCs) shows unprecedented promise in early-stage disease

Sylvester Cancer Tip Sheet for October 2025

Three science and technology leaders elected to Hertz Foundation Board of Directors

Jump Trading CSO Kevin Bowers elected to Hertz Foundation Board of Directors

Former Inscripta CEO Sri Kosaraju elected to Hertz Foundation Board of Directors

Citadel’s Jordan Chetty elected to Hertz Foundation Board of Directors

McGill research flags Montreal snow dump, inactive landfills as major methane polluters

A lightweight and rapid bidirectional search algorithm

Eighty-five years of big tree history available in one place for the first time

MIT invents human brain model with six major cell types to enable personalized disease research, drug discovery

Health and economic air quality co-benefits of stringent climate policies

How immune cells deliver their deadly cargo

How the brain becomes a better listener: How focus enhances sound processing

Processed fats found in margarines unlikely to affect heart health

Scientists discover how leukemia cells evade treatment

Sandra Shi MD, MPH, named 2025 STAT Wunderkind

Treating liver disease with microscopic nanoparticles

Chemicals might be hitching a ride on nanoplastics to enter your skin

Pregnant patients with preexisting high cholesterol may have elevated CV risk

UC stroke experts discuss current and future use of AI tools in research and treatment

The Southern Ocean’s low-salinity water locked away CO2 for decades, but...

OHSU researchers develop functional eggs from human skin cells

Most users cannot identify AI bias, even in training data

Hurricane outages: Analysis details the where, and who, of increased future power cuts

Craters on surface of melanoma cells found to serve as sites for tumor killing

Research Spotlight: Mapping overlooked challenges in stroke recovery

Geographic and temporal patterns of screening for breast, cervical, and colorectal cancer in the US

[Press-News.org] Finding about classic suppressor of immunity points toward new therapies for bad infections